Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,663 shares of the medical equipment provider’s stock after buying an additional 976 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Intuitive Surgical were worth $8,677,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. LGT Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the period. Delos Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. Insiders have sold 53,120 shares of company stock valued at $25,528,753 in the last quarter. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $521.15 on Friday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The business’s fifty day moving average is $483.85 and its 200-day moving average is $438.17. The stock has a market cap of $184.85 billion, a PE ratio of 94.07, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period in the previous year, the company earned $1.18 earnings per share. Intuitive Surgical’s revenue was up 14.5% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.